OptimizeRx Corp — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2020-03-31

Reporting Person: FEBBO WILLIAM J (Director, CHIEF EXECUTIVE OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-31	Common Stock	M	21187	—	Acquired	250906	Direct
2020-09-30	Common Stock	M	21186	—	Acquired	272092	Direct
2020-12-31	Common Stock	M	21186	—	Acquired	293278	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-31	Unvested Restricted Stock Award	$	M	21187	Disposed	2020-12-31	Common Stock (84746)	Direct
2020-09-30	Unvested Restricted Stock Award	$	M	21186	Disposed	2020-12-31	Common Stock (84746)	Direct
2020-12-31	Unvested Restricted Stock Award	$	M	21186	Disposed	2020-12-31	Common Stock (84746)	Direct

Footnotes

F1: The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 25% at the end of each quarter starting on 3/31/2020, and 21,187, 21,187, 21,186 and 21,186 shares vested as of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020, respectively.